Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

103.27
Delayed Data
As of 4:00pm ET
 -2.04 / -1.94%
Today’s Change
87.50
Today|||52-Week Range
139.79
+1.63%
Year-to-Date

Today’s Trading

Previous close105.31
Today’s open105.18
Day’s range102.61 - 105.18
Volume229,389
Average volume (3 months)309,112
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+1,833.30%
Earnings growth (this year)+0.74%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio368.8
Price/Sales32.00
Price/Book8.85

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...-1.41-2.80%
SAGESAGE Therapeutics In...-2.13-3.33%
IRWDIronwood Pharmaceuti...-0.25-1.46%
PRTAProthena Corporation...0.000.00%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$1.31
Annual revenue (last year)$71.9M
Annual profit (last year)$229.8M
Net profit margin319.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs